about
Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failureCommentary: vertebral ostium stenting: unsolved puzzle.High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.Assessment of the cost-effectiveness and clinical outcomes of a fourth-generation synchronous telehealth program for the management of chronic cardiovascular disease.The prognostic value of non-linear analysis of heart rate variability in patients with congestive heart failure--a pilot study of multiscale entropy.Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.Multi-scale symbolic entropy analysis provides prognostic prediction in patients receiving extracorporeal life supportInfluence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability.Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronismOutlier-resilient complexity analysis of heartbeat dynamicsAdministrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan.Detrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis.Reversible heart rhythm complexity impairment in patients with primary aldosteronism.Complexity of cardiac signals for predicting changes in alpha-waves after stress in patients undergoing cardiac catheterizationUse of Extracorporeal Membrane Oxygenation to Rescue Patients With Refractory Ventricular Arrhythmia in Acute Myocardial Infarction.Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone.Clinical outcome and cost-effectiveness of a synchronous telehealth service for seniors and nonseniors with cardiovascular diseases: quasi-experimental studyEvaluation of myocardial infarction patients after coronary revasculation by dual-phase multi-detector computed tomography: Now and in future.Mortality Benefit of a Fourth-Generation Synchronous Telehealth Program for the Management of Chronic Cardiovascular Disease: A Longitudinal Study.Dual benefits of renin-angiotensin-aldosterone blockade: lowering the blood pressure and de-stiffening the arteries.Management of patients with implantable cardioverter defibrillators at emergency departments.Long term outcome of Aldosteronism after target treatments.The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes.Identification of Atrial Fibrillation by Quantitative Analyses of Fingertip Photoplethysmogram.Diagnosis and management of primary aldosteronism: an updated review.Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension--A single-center experience in Taiwan.Plasma leptin levels and digital pulse volume in obese patients without metabolic syndrome--a pilot study.The relationship among cardiac structure, dietary salt and aldosterone in patients with primary aldosteronism.In vivo assessment of cardiac morphology and function in heart-specific green fluorescent zebrafish.Coronary artery fistula presented as infective endocarditis with pulmonary septic emboli.Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy.Angiotensin-converting enzyme gene polymorphism in children with idiopathic nephrotic syndrome.Association of the variations in the HSD3β gene with primary aldosteronism.Conditional antisense-knockdown of zebrafish cardiac troponin C as a new animal model for dilated cardiomyopathy.WITHDRAWN: Association between the levels of carboxy-terminal propeptide of type I procollagen and aldosterone in patients with primary aldosteronism and essential hypertension.Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide.The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study.Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.Increased night duty loading of physicians caused elevated blood pressure and sympathetic tones in a dose-dependent manner.
P50
Q28483052-30D22101-52BD-423F-AB61-E229996E50A8Q33349000-BAB61F1B-EF54-416B-96B5-B8CAE87F93A3Q33372462-FDDC8983-C59E-4141-A708-1D4B4C0EC77CQ33807769-71D31C9C-DD6A-4EC9-8090-FA3DC54548E3Q33886836-4E6F0346-E641-4AA3-B642-738053F87DB4Q34122713-8172575F-B62F-491C-ACB4-2FE3932718B3Q34460112-F61FC2CE-765D-4CC6-8A4C-3A646F70CFF1Q34692362-E05A7357-277A-4933-BE23-A57857B15016Q34807314-E682F889-FE6E-4C40-A7A6-A379D0878F08Q35153288-B4D83395-0BFB-4F3C-9522-9C4A164539BDQ35208504-3E7D94AB-386D-4E48-AE34-A8B55091D71EQ35909295-7877D281-0AC6-4443-A4F6-740A6FF2647DQ35964224-A22ED7C5-48F5-4E27-87E5-0476D849B022Q35969533-D559C7D9-93C8-4677-987D-C954ADF3EA4DQ36009320-12537F18-4CE4-4A24-9E10-A106F8E0992FQ36174691-5E0FC8B7-2485-4DEF-93FC-186422DF3918Q36795024-E4EDFA0B-0617-4842-89E0-9B369523B9ACQ36840835-0DE5CC87-9761-4527-AE09-522F7A6460FCQ37008543-CF2938DA-1BD2-4182-A9F2-928A2F6D3317Q37121385-F5581340-0754-4DE1-9B31-AEBAC0E1F080Q37134585-C9E26576-13BE-477A-A57A-1948EB461A37Q37227936-71A446B7-84B7-4F3F-B8A8-445A60EFAFE1Q37593326-D30D65A8-CA88-4577-B1BE-FC1B1C2E51A7Q37734662-8CB0BECA-D07B-4DE0-8F9E-596302B5E33DQ38108818-7AD9102E-5D1B-4AC4-A9B9-E8FC97B1DD1CQ38255385-E76BF937-C0D4-4A31-BDCD-910C07429D9AQ39964826-2E3778E1-7BA3-41E5-9CC7-235D6E925217Q42700680-710C5923-1DCE-4933-BB20-8D6388342D87Q43714189-8AD163B8-1EC9-438B-BF43-BB49FE488239Q43803771-39B2D4FB-16F5-4B41-A399-2C88B6982E76Q44083089-A461C270-8599-4A66-B198-BCF4585E8DA7Q44982668-A47442C1-31D1-4E2B-903A-E8BFF32C5D04Q45216829-67390408-D4D2-4E34-B058-A8D668FC6926Q45361104-D8605DAE-2D14-4FCB-A2A5-87588CCB3180Q45789884-289C0177-5830-434A-AA37-7933B90818C6Q45949814-C6EC7322-E6BE-4D0B-A6F2-F8F57F3FFE1CQ47148464-7C3BD6DE-925C-450E-B807-FDFB0D9A5677Q47571995-739C3724-8CEB-47F0-B994-BEDCE5960B0DQ47783813-F19FE827-5AFD-4354-A303-A5918100A85EQ47950613-3CF2B182-A66F-4D40-97B7-94449FADF58F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yen-hung Lin
@ast
Yen-hung Lin
@en
Yen-hung Lin
@es
Yen-hung Lin
@nl
Yen-hung Lin
@sl
type
label
Yen-hung Lin
@ast
Yen-hung Lin
@en
Yen-hung Lin
@es
Yen-hung Lin
@nl
Yen-hung Lin
@sl
altLabel
林彥宏
@en
prefLabel
Yen-hung Lin
@ast
Yen-hung Lin
@en
Yen-hung Lin
@es
Yen-hung Lin
@nl
Yen-hung Lin
@sl
P108
P106
P108
P1153
25522123900
P31
P496
0000-0001-8153-1441